334 related articles for article (PubMed ID: 32069845)
1. Mitogen-Activated Protein Kinase (MAPK) and Obesity-Related Cancer.
Donohoe F; Wilkinson M; Baxter E; Brennan DJ
Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32069845
[TBL] [Abstract][Full Text] [Related]
2. MXD3 Promotes Obesity and the Androgen Receptor Signaling Pathway in Gender-Disparity Hepatocarcinogenesis.
Tsai YW; Jeng KS; He MK; Hsieh YW; Lai HH; Lai CY; Huang CC; Chang CF; Huang CT; Her GM
Cells; 2021 Dec; 10(12):. PubMed ID: 34943942
[TBL] [Abstract][Full Text] [Related]
3. Oncogenic mutations and dysregulated pathways in obesity-associated hepatocellular carcinoma.
Shen J; Tsoi H; Liang Q; Chu ES; Liu D; Yu AC; Chan TF; Li X; Sung JJ; Wong VW; Yu J
Oncogene; 2016 Dec; 35(49):6271-6280. PubMed ID: 27132506
[TBL] [Abstract][Full Text] [Related]
4. Autophagy and non-alcoholic fatty liver disease.
Lavallard VJ; Gual P
Biomed Res Int; 2014; 2014():120179. PubMed ID: 25295245
[TBL] [Abstract][Full Text] [Related]
5. Hepatocellular carcinoma and non-alcoholic steatohepatitis: The state of play.
Charrez B; Qiao L; Hebbard L
World J Gastroenterol; 2016 Feb; 22(8):2494-502. PubMed ID: 26937137
[TBL] [Abstract][Full Text] [Related]
6. p38 mitogen-activated protein kinase pathway is involved in protein kinase Calpha-regulated invasion in human hepatocellular carcinoma cells.
Hsieh YH; Wu TT; Huang CY; Hsieh YS; Hwang JM; Liu JY
Cancer Res; 2007 May; 67(9):4320-7. PubMed ID: 17483345
[TBL] [Abstract][Full Text] [Related]
7. GADD34-deficient mice develop obesity, nonalcoholic fatty liver disease, hepatic carcinoma and insulin resistance.
Nishio N; Isobe K
Sci Rep; 2015 Aug; 5():13519. PubMed ID: 26316333
[TBL] [Abstract][Full Text] [Related]
8. Cancer-related gene expression is associated with disease severity and modifiable lifestyle factors in non-alcoholic fatty liver disease.
Arendt BM; Teterina A; Pettinelli P; Comelli EM; Ma DWL; Fung SK; McGilvray ID; Fischer SE; Allard JP
Nutrition; 2019 Jun; 62():100-107. PubMed ID: 30870804
[TBL] [Abstract][Full Text] [Related]
9. Non-alcoholic fatty liver disease associated with hepatocellular carcinoma: An increasing concern.
Dhamija E; Paul SB; Kedia S
Indian J Med Res; 2019 Jan; 149(1):9-17. PubMed ID: 31115369
[TBL] [Abstract][Full Text] [Related]
10. Stress kinases in the development of liver steatosis and hepatocellular carcinoma.
Cicuéndez B; Ruiz-Garrido I; Mora A; Sabio G
Mol Metab; 2021 Aug; 50():101190. PubMed ID: 33588102
[TBL] [Abstract][Full Text] [Related]
11. Liver Cancer: Connections with Obesity, Fatty Liver, and Cirrhosis.
Marengo A; Rosso C; Bugianesi E
Annu Rev Med; 2016; 67():103-17. PubMed ID: 26473416
[TBL] [Abstract][Full Text] [Related]
12. Dual Shp2 and Pten Deficiencies Promote Non-alcoholic Steatohepatitis and Genesis of Liver Tumor-Initiating Cells.
Luo X; Liao R; Hanley KL; Zhu HH; Malo KN; Hernandez C; Wei X; Varki NM; Alderson N; Chu C; Li S; Fan J; Loomba R; Qiu SJ; Feng GS
Cell Rep; 2016 Dec; 17(11):2979-2993. PubMed ID: 27974211
[TBL] [Abstract][Full Text] [Related]
13. Apoptosis and non-alcoholic fatty liver diseases.
Kanda T; Matsuoka S; Yamazaki M; Shibata T; Nirei K; Takahashi H; Kaneko T; Fujisawa M; Higuchi T; Nakamura H; Matsumoto N; Yamagami H; Ogawa M; Imazu H; Kuroda K; Moriyama M
World J Gastroenterol; 2018 Jul; 24(25):2661-2672. PubMed ID: 29991872
[TBL] [Abstract][Full Text] [Related]
14. Animal Models of Non-alcoholic Fatty Liver Diseases and Its Associated Liver Cancer.
Lau JKC; Zhang X; Yu J
Adv Exp Med Biol; 2018; 1061():139-147. PubMed ID: 29956212
[TBL] [Abstract][Full Text] [Related]
15. NAFLD Related-HCC: The Relationship with Metabolic Disorders.
Zhang X
Adv Exp Med Biol; 2018; 1061():55-62. PubMed ID: 29956206
[TBL] [Abstract][Full Text] [Related]
16. Bioinformatics analysis reveals novel core genes associated with nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.
Feng G; Li XP; Niu CY; Liu ML; Yan QQ; Fan LP; Li Y; Zhang KL; Gao J; Qian MR; He N; Mi M
Gene; 2020 Jun; 742():144549. PubMed ID: 32184169
[TBL] [Abstract][Full Text] [Related]
17. Resolvin D1 reduces ER stress-induced apoptosis and triglyceride accumulation through JNK pathway in HepG2 cells.
Jung TW; Hwang HJ; Hong HC; Choi HY; Yoo HJ; Baik SH; Choi KM
Mol Cell Endocrinol; 2014 Jun; 391(1-2):30-40. PubMed ID: 24784707
[TBL] [Abstract][Full Text] [Related]
18. Lipidomic biomarkers and mechanisms of lipotoxicity in non-alcoholic fatty liver disease.
Svegliati-Baroni G; Pierantonelli I; Torquato P; Marinelli R; Ferreri C; Chatgilialoglu C; Bartolini D; Galli F
Free Radic Biol Med; 2019 Nov; 144():293-309. PubMed ID: 31152791
[TBL] [Abstract][Full Text] [Related]
19. Lipid Related Genes Altered in NASH Connect Inflammation in Liver Pathogenesis Progression to HCC: A Canonical Pathway.
Desterke C; Chiappini F
Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31717414
[TBL] [Abstract][Full Text] [Related]
20. Nonalcoholic Fatty liver disease, diabetes, obesity, and hepatocellular carcinoma.
Noureddin M; Rinella ME
Clin Liver Dis; 2015 May; 19(2):361-79. PubMed ID: 25921668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
